Literature DB >> 9754396

Drugs detected in patients suspected of acute intoxication.

L B Baskin1, D L Morgan.   

Abstract

Drug screens were performed for 434 adult patients who presented to the Parkland Memorial Hospital Emergency Department with suspected acute drug overdose. The screening consisted of analysis of urine by automated high performance liquid chromatography (REMEDi) in combination with qualitative EMIT immunoassays. Selected patients also had ethanol measured in blood, salicylate and acetaminophen measured in serum, and urine specimens analyzed qualitatively for cannabinoids. Most patients (83.4%), regardless of age, race, or gender, had evidence of consumption of at least one drug. The drugs detected most often were ethanol (30.0%) and cocaine (23.7%). At least one of the nine most common drugs-of-abuse (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, opiates, opioids, and phencyclidine) was detected in 64.5% of the specimens, and combinations of these drugs were present in 45.4%. For most drugs, age, gender, ethnicity, time of day, day of week, and indication for screening could not be used to predict the drug screen result.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9754396

Source DB:  PubMed          Journal:  Tex Med        ISSN: 0040-4470


  3 in total

1.  Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose.

Authors:  A Fabbri; G Marchesini; A M Morselli-Labate; S Ruggeri; M Fallani; R Melandri; V Bua; A Pasquale; A Vandelli
Journal:  Emerg Med J       Date:  2003-01       Impact factor: 2.740

2.  Measuring plasma salicylate concentrations in all patients with drug overdose or altered consciousness: is it necessary?

Authors:  D M Wood; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-06       Impact factor: 2.740

3.  A combined HPLC-immunoenzymatic comprehensive screening for suspected drug poisoning in the emergency department.

Authors:  A Fabbri; S Ruggeri; G Marchesini; A Vandelli
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.